The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
Sophie L. Stocker(University of California, San Francisco), KM Giacomini(University of California, San Francisco), Kari M. Morrissey(University of California, San Francisco), Andrea H. Ramirez(Vanderbilt University Medical Center), Lijun Xu(University of California, San Francisco), Christopher M. A. Brett(Center for Economic and Policy Research), Catherine A. McCarty(University of Minnesota, Duluth), Dan M. Roden(Garvan Institute of Medical Research), Robert L. Davis(Southeast Health District), Amber Dahlin(University of California, San Francisco), Russell A. Wilke(Vanderbilt University Medical Center), R A Castro(University of California, San Francisco), Sook Wah Yee(Pfizer (United States))
Cited by 189
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Electrochemistry: Principles, Methods, and Applications
|Medical Entomology and Zoology|1993|1k
Deep eutectic solvents for the production and application of new materials
|Applied Materials Today|2017|686